Dingdang Health adds 621,000-share buyback on 5 June; 7.39 million shares now pending cancellation

Bulletin Express06-05

Dingdang Health Technology Group Ltd. disclosed a Next Day Disclosure Return showing continued execution of its share repurchase programme.

The company repurchased 621,000 ordinary shares on 5 June 2026 via on-market transactions at prices ranging from HKD 0.79 to HKD 0.87, for an aggregate consideration of HKD 0.53 million.

Including this latest tranche, Dingdang Health has bought back 7.39 million shares between 19 May and 5 June 2026 that are earmarked for cancellation but had not yet been cancelled as of 5 June. The cumulative purchases represent approximately 0.59 % of the company’s 1.25 billion issued shares and were executed at an estimated average price of HKD 0.90, bringing total cash outlay during the period to about HKD 6.64 million.

Despite the buybacks, the company’s issued share capital remained unchanged at 1,254.65 million shares as of 5 June 2026, pending the formal cancellation of the repurchased stock.

Under the repurchase mandate granted on 28 May 2025, Dingdang Health is authorised to repurchase up to 131.95 million shares. To date, 72.22 million shares, or 5.47 % of the issued share base on the mandate date, have been repurchased on the market. In accordance with Hong Kong listing rules, the company is subject to a moratorium on new share issues until 5 July 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1144970480?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-05 19:08","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1144970480","market":"us","top_or_hot":-1,"title":"Dingdang Health adds 621,000-share buyback on 5 June; 7.39 million shares now pending cancellation","media":"Bulletin Express","content":"<p>Dingdang Health Technology Group Ltd. disclosed a Next Day Disclosure Return showing continued execution of its share repurchase programme.</p>\n<p>The company repurchased 621,000 ordinary shares on 5 June 2026 via on-market transactions at prices ranging from HKD 0.79 to HKD 0.87, for an aggregate consideration of HKD 0.53 million.</p>\n<p>Including this latest tranche, Dingdang Health has bought back 7.39 million shares between 19 May and 5 June 2026 that are earmarked for cancellation but had not yet been cancelled as of 5 June. The cumulative purchases represent approximately 0.59 % of the company’s 1.25 billion issued shares and were executed at an estimated average price of HKD 0.90, bringing total cash outlay during the period to about HKD 6.64 million.</p>\n<p>Despite the buybacks, the company’s issued share capital remained unchanged at 1,254.65 million shares as of 5 June 2026, pending the formal cancellation of the repurchased stock.</p>\n<p>Under the repurchase mandate granted on 28 May 2025, Dingdang Health is authorised to repurchase up to 131.95 million shares. To date, 72.22 million shares, or 5.47 % of the issued share base on the mandate date, have been repurchased on the market. In accordance with Hong Kong listing rules, the company is subject to a moratorium on new share issues until 5 July 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dingdang Health adds 621,000-share buyback on 5 June; 7.39 million shares now pending cancellation</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDingdang Health adds 621,000-share buyback on 5 June; 7.39 million shares now pending cancellation\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-05 19:08</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Dingdang Health Technology Group Ltd. disclosed a Next Day Disclosure Return showing continued execution of its share repurchase programme.</p>\n<p>The company repurchased 621,000 ordinary shares on 5 June 2026 via on-market transactions at prices ranging from HKD 0.79 to HKD 0.87, for an aggregate consideration of HKD 0.53 million.</p>\n<p>Including this latest tranche, Dingdang Health has bought back 7.39 million shares between 19 May and 5 June 2026 that are earmarked for cancellation but had not yet been cancelled as of 5 June. The cumulative purchases represent approximately 0.59 % of the company’s 1.25 billion issued shares and were executed at an estimated average price of HKD 0.90, bringing total cash outlay during the period to about HKD 6.64 million.</p>\n<p>Despite the buybacks, the company’s issued share capital remained unchanged at 1,254.65 million shares as of 5 June 2026, pending the formal cancellation of the repurchased stock.</p>\n<p>Under the repurchase mandate granted on 28 May 2025, Dingdang Health is authorised to repurchase up to 131.95 million shares. To date, 72.22 million shares, or 5.47 % of the issued share base on the mandate date, have been repurchased on the market. In accordance with Hong Kong listing rules, the company is subject to a moratorium on new share issues until 5 July 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09886","symbol_name":"叮当健康","start_time":0,"source_url":"","article_id":"1144970480","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1144970480","pubTimestamp":1780657700,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Dingdang Health Technology Group Ltd. disclosed a Next Day Disclosure Return showing continued execution of its share repurchase programme. The company repurchased 621,000 ordinary shares on 5 June...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09886":"叮当健康"},"translate_title":"叮当健康6月5日追加回购62.1万股；739万股目前等待注销","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09886":1},"content_text":"Dingdang Health Technology Group Ltd. disclosed a Next Day Disclosure Return showing continued execution of its share repurchase programme.\nThe company repurchased 621,000 ordinary shares on 5 June 2026 via on-market transactions at prices ranging from HKD 0.79 to HKD 0.87, for an aggregate consideration of HKD 0.53 million.\nIncluding this latest tranche, Dingdang Health has bought back 7.39 million shares between 19 May and 5 June 2026 that are earmarked for cancellation but had not yet been cancelled as of 5 June. The cumulative purchases represent approximately 0.59 % of the company’s 1.25 billion issued shares and were executed at an estimated average price of HKD 0.90, bringing total cash outlay during the period to about HKD 6.64 million.\nDespite the buybacks, the company’s issued share capital remained unchanged at 1,254.65 million shares as of 5 June 2026, pending the formal cancellation of the repurchased stock.\nUnder the repurchase mandate granted on 28 May 2025, Dingdang Health is authorised to repurchase up to 131.95 million shares. To date, 72.22 million shares, or 5.47 % of the issued share base on the mandate date, have been repurchased on the market. In accordance with Hong Kong listing rules, the company is subject to a moratorium on new share issues until 5 July 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1144970480","isCrawlerRequest":true}